BD's business encompasses the research, development, manufacture and sale of medical devices, medical systems and reagents to improve human health worldwide. The company focuses on improving drug delivery, increasing the quality and speed of diagnosis of infectious diseases and cancer, and advancing the development and production of novel drugs and vaccines.BD's businesses are organized into three main categories: BD Medical, BD Life Sciences and BD Interventions. The company serves medical institutions, life science research institutes, clinical laboratories, industrial units and the general public.BD registered and established a representative office in China in 1994, and set up a manufacturing enterprise in Suzhou Industrial Park, Jiangsu Province, in 1995.BD launched its products in the Chinese market, including medical, diagnostic, and bioscience products, and has nearly 2,500 employees, which, through consolidation, have formed the company's headquarters in China, Shanghai, Beijing, Guangzhou and Shanghai. Through the integration, it has formed a business pattern with Shanghai as the headquarter of China and fourteen offices in Beijing and Guangzhou as the core.